Pseudomonas aeruginosa harbors a type III secretion system that translocates antihost effectors into an infected eukaryotic cell. PcrH is a key component of type III secretion in this essential virulence strategy. In the absence of PcrH, P. aeruginosa is translocation deficient because of a specific reduction in presecretory stability and subsequent secretion of PopB and PopD, 2 proteins essential for the translocation process. PcrH exerts this chaperone function by binding directly to PopB and PopD. Consistent with the genetic relatedness of PcrH with LcrH of pathogenic Yersinia species, these proteins are functionally interchangeable with respect to their ability to complement the translocation defect associated with either a lcrH or pcrH null mutant, respectively. Thus, the translocator class of chaperones performs a critical function in ensuring the assembly of a translocation competent type III secreton. Finally, unlike the regulatory roles of other translocator-class chaperones (e.g., LcrH, SicA of Salmonella enterica, and IpgC of Shigella species), in vitro regulation of P. aeruginosa type III secretion does not involve PcrH.
Despite being commonly found in the environment, the opportunistic pathogen Pseudomonas aeruginosa is extremely efficient at establishing severe and persistent infections in patients with compromised host defenses [1] . Although patients with AIDS or those receiving chemotherapy or immunosuppressive drug therapy naturally account for numerous infections, P. aeruginosa also has the unique ability to cause severe disease in patients with acute burns or cystic fibrosis and in long-time users of contact lenses [1] . This versatility, together with its intrinsic multidrug resistance [2] , ensures that P. aeruginosa is the cause of significant mortality and morbidity.
Several secreted and cell surface-associated components produced by P. aeruginosa likely contribute to the virulence propensity of this organism [3] . Factors such as exotoxins, proteases, pili, flagella, endotoxins, and exopolysaccharides enable P. aeruginosa to establish colonization in a variety of host niches. However, the recent identification of a type III secretion system (TTSS) in P. aeruginosa is an important discovery. As for an ever-growing variety of bacterial pathogens [4] , this secretion system enables P. aeruginosa to translocate the exoenzyme cytotoxins into host cells, where they act to subvert normal host-cell signaling [1, 4] . Two proteins encoded by the pcrGVHpopBD operon [5] , PopB and PopD, are absolutely essential for toxin translocation [6] [7] [8] . Remarkably, this operon is structurally and genetically similar to the lcrGVHyopBD translocase operon of the plasmid-encoded TTSS of pathogenic Yersinia species [9] .
Three pathogenic Yersinia species use a TTSS to cause disease that ranges from self-limiting gastrointestinal infections (Y. pseudotuberculosis and Y. enterocolitica) to the fatal bubonic or pneumonic plague (Y. pestis) [10] . Like PopB and PopD of P. aeruginosa, secreted YopB and YopD are responsible for effector translocation by Yersinia species and are essential for virulence [11] [12] [13] . YopB and YopD function intimately depends on the type III secretion chaperone LcrH (also known as SycD), which is responsible for the presecretory stabilization of YopB and YopD and ensures their efficient secretion [14] [15] [16] .
Type III secretion chaperones are unusual members of the "classic" chaperone family because they exhibit an intriguing specificity for predominantly 1 or, at most, a few secreted substrates [17, 18] . It was initially recognized that these chaperones functioned to prevent premature aggregation of newly synthesized polypeptides and to ensure their subsequent secretion [19] . In addition, an important role for a type III secretion hierarchy has also been established [20] [21] [22] , which seems logical, because substrates required early in an infection need to be secreted first. In addition, recent studies of a variety of pathogenic bacteria have defined a new role for a subset of these chaperones. The "translocator class" of chaperones also regulates the expression of the secreted substrates [23] [24] [25] . LcrH of Yersinia species is one such example because it is absolutely essential for regulatory control of Yop effector synthesis [26, 27] . Collectively, the dual roles of translocator-class type III chaperones evoke a role for them as molecular switches during a bacterial infection; by guaranteeing the correct pattern of substrate secretion by TTSSs they, in turn, confer appropriate spatial and temporal gene expression.
Because chaperones are key mediators of the TTSS virulence strategy, we set out to investigate the role of PcrH, which was recently shown to bind both PopB and PopD [28] , in assembly and regulation of the type III secretion translocon of the pathogen P. aeruginosa. We show that PcrH is responsible for the presecretory stabilization and efficient secretion of the PopB and PopD translocators. However, we demonstrate that, unlike some other translocator-class chaperones, PcrH was not involved in the in vitro regulation of type III secretion.
MATERIALS AND METHODS
Strains, plasmids, culture media, and growth conditions. The microbes and plasmids used in the present study are listed in table 1. Unless otherwise indicated, bacteria were routinely grown in Luria-Bertini (LB) broth or on blood agar base plates (Merck) with aeration at either 26ЊC (Y. pseudotuberculosis) or 37ЊC (Escherichia coli or P. aeruginosa). Where appropriate, the following antibiotics were used: ampicillin (100 mg/mL), kanamycin (50 mg/mL), chloramphenicol (25 mg/mL), and gentamicin (Gm; 20 mg/mL). Routine culturing of yeast strains was done according to a procedure described elsewhere [26] .
Recombinant DNA techniques, enzymes, and reagents. Isolation of plasmid DNA from E. coli strains was performed by use of the High Purification Plasmid Miniprep kit (Roche Applied Science). Standard DNA manipulation techniquesincluding use of restriction enzymes, in vitro DNA cloning, DNA mobilization, and agarose gel electrophoresis-have been described elsewhere [36] . Recovery of DNA fragments from agarose was achieved by either Geneclean II (Bio 101) or Genelute minus EtBr spin columns (Sigma), as described by the manufacturer. All modifying enzymes were purchased from New England Biolabs or MBI Fermentas and were used according to the manufacturers' specifications. The polymerase chain reaction (PCR) conditions used to amplify DNA fragments from P. aeruginosa PAK included the use of 0ϫ-1.5ϫ PCR Enhancer Solution (Invitrogen Life Technologies) and DyNAzyme II DNA polymerase (Finnzymes). All oligonucleotides (purchased from MWG-Biotech AG) were designed in regions of absolute identity between sequences obtained from P. aeruginosa strain 388 (GenBank accession number AF010149) [5] and the Pseudomonas Genome Project (strain PAO1) [37] . All PCR-amplified alleles were sequenced using the DYEnamic ET terminator cycle sequencing kit (Amersham Biosciences). The nucleotide sequence of the pcrH region has been deposited in GenBank (accession number AY232997).
Mutant construction and cis-complementation in P. aeruginosa. Generation of the mutagenesis vector pJEB42 used to construct the in-frame DpcrH mutation in PAK (wild type) of P. aeruginosa was performed as follows: PCR-amplified DNA fragments were generated by overlap PCR [38] with the primers A1 (5 -GCA TGT CTC GAG GCT GAC CGC GGA GTT GAA GG-3 ; XhoI), B1 (5 -GGT CGC TTG CTG GTT CAT-3 ), C1  (5 -AAC CAG CAA GCG ACC ATG TTG GAA GCC GTA ACC-3 ), and D1 (5 -GCA TGT GCA TGT GCA TGC TCC CTG  ATC TTC TGC TGG TTG TC-3 ; SphI) . (In all the primers listed in this article, underlined sequences refer to the introduced restriction enzyme site.) The resulting 996-bp fragment contained sequence flanking the pcrH gene with an in-frame deletion of codons 7-149. The fragment was introduced into XhoI-SphI-digested pDM4-Gm to yield pJEB42. To generate pDM4-Gm, a Gm cassette derived from SalI-digested p34S-Gm [35] was cloned into the SalI site of the suicide vector pDM4 [32] . This facilitated the subsequent selection in P. aeruginosa after conjugation of pJEB42. To generate pJEB62 for the ciscomplementation of the DpcrH null mutant, a 1428-bp fragment incorporating wild-type pcrH and corresponding flanking regions was generated by PCR with the primer pair A1 and D1. The amplified fragment was introduced into pCR4-TOPO (Invitrogen), confirmed by sequence, and excised by use of EcoRI. This fragment was subcloned into EcoRI-digested pEX18Gm [33] to yield pJEB62. S17-1lpir was used as the donor strain in conjugational experiments with P. aeruginosa. Allelic exchange of the pJEB42 and pJEB62 suicide plasmids within regions of complementary sequence on the PAK and PAKpcrH chromosome, respectively, was achieved by sucrose selection, as described elsewhere [32] . The engineered PAKpcrH mutant and cis-complemented strain were verified by PCR and Western-blot analysis.
Construction of trans-complementation expression plasmids. To clone pcrH with its native ribosome-binding site for complementation in studies of Y. pseudotuberculosis, the primer pair combination of PcrH-F (5 -GCA TGT AAG CTT GAT CTA GAG GTA TCC ATG-3 ; HindIII) and PcrH-R (5 -GCA TGT GTC GAC TCA AGC GTT ATC GGA TTC A-3 ; SalI) was used in the PCR. The amplified product was initially cloned into the pCR4-TOPO cloning vector (Invitrogen) for sequence confirmation and then subcloned into HindIII/ SalI-digested pMMB66HE [34] , yielding pJEB46. To generate pSEB1-Gm for synthesis of LcrH in P. aeruginosa, a Gm cassette isolated from BamHI-digested p34S-Gm [35] was introduced into the BamHI site of pSEB1. Chemical transformation into E. coli was performed as described elsewhere [39] , as was the method of electroporation into Y. pseudotuberculosis [40] . DNA mobilization into P. aeruginosa was achieved by standard conjugation methods, and the conjugates were enriched by growth on M9 minimal media containing 20 mg/mL Gm. Synthesis and secretion of type III-secreted substrates. Induction of type III substrate synthesis and secretion from Y. pseudotuberculosis [9] and P. aeruginosa [8] was performed by standard methods, except that, to induce expression from constructs under the control of the P tac promoter, isopropyl-b-dthiogalactopyranoside (IPTG) was added, to a final concentration of 0.4 mmol/L, at the time of temperature increase during induction. Western-blot analysis of total protein levels sampled directly from the bacterial culture suspension (containing a mix of proteins secreted into the culture medium and within intact bacteria) and of cleared supernatants (containing only proteins secreted into the culture medium) was performed as described elsewhere [41] .
Magnesium oxalate analysis. To provide insight into the regulatory status of Y. pseudotuberculosis type III secretion, plating frequencies of the different mutant strains grown at 37ЊC with or without Ca 2+ were determined as described elsewhere [9] . In brief, the plating frequency reflects the ability to form colonies at 37ЊC, compared with the ability to form colonies at 26ЊC. The frequency is given as a ratio of the number of colonies growing at 37ЊC to the number growing at 26ЊC. Normal regulatory control correlates to Ca 2+ -dependent growth, whereas a loss of negative regulatory control correlates with the inability to grow at 37ЊC, regardless of Ca 2+ levels. [42] or P. aeruginosa [8] followed our standard methods, except that IPTG (0.4 mmol/L) was added to both bacteria and cell monolayers before infection. The cytotoxicity of infected HeLa cells was monitored by light microscopy, and images were obtained at successive time points.
Cultivation and infection of HeLa cells. The human epithelial cell line HeLa was used in all in vitro infection experiments. Culture maintenance and infections with Y. pseudotuberculosis
RNA isolation and reverse-transcriptase (RT) PCR. The P. aeruginosa PAK and PAKpcrH strains were grown overnight at 37ЊC in LB broth supplemented with 2.5 mmol/L CaCl 2 (i.e., with Ca ). After subculturing a 0.03 volume in 10 mL of fresh media before a further 2-h incubation, total RNA was isolated by use of the RNeasy minikit (Qiagen GmbH) in combination with RNAprotect bacteria reagent (Qiagen) and an on-column DNase treatment (Qiagen), according to the manufacturer's directions. mRNA was then enriched from 10 mg of total RNA by use of a specialized Pseudomonas MICROBExpress bacterial mRNA enrichment kit (Ambion); 0.1 mg of enriched mRNA was then reverse-transcribed in a total volume of 20 mL by use of random primers contained in the ImProm-II reverse transcription system (Promega) or in identical control reactions in which the enzyme was omitted. The second-step PCR (final volume, 20 mL) amplification of cDNA template was performed by use of primers specific for each of the genes: pcrV (bp 566-885), pcrH (bp 1-369), popB (bp 845-1173), popD (bp 12-569), exoS (bp 793-1362), and exoT (bp 1046-1437). To accommodate for the different efficiencies of DNA amplification by the gene-specific primers, a 0.05 volume of template was added for amplification of pcrH, popD, and exoT; a 0.005 volume was added for amplification of pcrV; and a 0.001 volume was added for amplification of popB and exoS. The cycling conditions used were initial denaturation at 95ЊC for 5 min, then denaturation at 95ЊC for 30 s, annealing at 55ЊC for 30 s, and extension at 72ЊC for 40 s (30 cycles), before a final extension at 72ЊC for 10 min in an iCycler Thermal Cycler (Bio-Rad). The PCR conditions used to amplify DNA included the use of 0.5ϫ-1ϫ PCR Enhancer Solution and DyNAzyme II DNA polymerase.
Yeast plasmid construction, transformation, and the 2-hybrid assay. popB (pJEB60) and popD (pJEB58) derived from P. aeruginosa PAK were cloned into the NdeI/EcoRI sites of the GAL4 DNA-binding domain plasmid pGBKT7 by use of the specific primer pairs PopB4-F (5 -ACT ACT CAT ATG ATG AAT CCG ATA ACG CTT-3 ; NdeI) and PopB2-R (5 -GCA TGT GAA TTC TCA GAT CGC TGC CGG TC-3 ; EcoRI), and PopD3-F (5 -ACT ACT CAT ATG ATG ATC GAC ACG CAA TA-3 ; NdeI) and PopD2-R (5 -GCA TGT GAA TTC AGA CGG CTC AGA CCA CT-3 ; EcoRI), respectively. Cloning of yopB (pMF368) and yopD (pMF367) of Y. pseudotuberculosis YPIII/pIB102 in the GAL4 DNA-binding domain of plasmid pGBKT7 has been described elsewhere [16] . pcrH (pJEB56) of strain PAK was cloned into the EcoRI/XhoI sites of the GAL4 activation domain plasmid pGADT7 by use of the specific pcrH primers PcrH3-F (5 -ACT ACT GAA TTC ATG AAC CAG CAA GCG ACC-3 ; EcoRI) and PcrH4-R (5 -ACT ACT CTC GAG TCA AGC GTT ATC GGA TTC A-3 ; XhoI). Construction of lcrH (pMF370) of YPIII/pIB102 in the GAL4 activation domain of plasmid pGADT7 has been reported elsewhere [16] . Transformation of the Saccharomyces cerevisiae reporter strain PJ69-4A, protein expression analysis of yeast lysates, and analysis of protein-protein interactions were performed according to our established methods [16] . In particular, interactions were determined by growth of yeast on synthetic dropout minimal agar (Clontech Laboratories) devoid of tryptophan, leucine, and adenine resulting from ADE2 reporter gene activation. The interactive potential of partner proteins was confirmed by (1) comparative growth at 25ЊC and 30ЊC to provide an insight into the relative energy required for each interaction, and (2) induction of an independent reporter gene (lacZ) by performing b-galactosidase assays of yeast strains grown in liquid culture [16] .
RESULTS
PcrH of P. aeruginosa is required for the stability and secretion of PopB and PopD. In Yersinia species, the type III secretion chaperone LcrH is responsible for presecretory stabilization and efficient secretion of YopB and YopD [14] [15] [16] . We wanted to investigate whether the PcrH homologue in P. aeruginosa [5] 2+ . Proteins were separated by SDS-PAGE and identified by immunoblotting by use of polyclonal rabbit anti-ExoS (cross-reacts with ExoT), anti-PcrV, antiYopB (cross-reacts with PopB), and anti-PopD antisera. Protein fractions were generated from a mix of proteins secreted to the culture medium and contained within intact bacteria (left) or cleared culture supernatants (right). Lanes: a and b, wild-type PAK; c and d, DpcrH deletion mutant PAKpcrH; and e and f, cis-complemented PAKpcrH + . Molecular weights shown in parentheses are deduced from primary sequence. The asterisk indicates an unidentified protein band of higher molecular weight that is detected by the anti-YopB antiserum. Biorad prestained low-range-protein molecular weight standards were used in this analysis.
(figure 1) functions as a customized chaperone for PopB and PopD. We engineered a nearly full-length in-frame deletion allele of pcrH (DpcrH ) and introduced this construct (pJEB42) into P. aeruginosa PAK, yielding the DpcrH null mutant PAKpcrH (figure 1). By retaining the last 18 C-terminal amino acids of PcrH, the overlapping translation initiation region of popB remained intact.
To investigate the levels of protein synthesis and secretion in the wild-type and isogenic DpcrH mutant grown under inducing (without Ca 2+ ) or noninducing (with Ca 2+ ) conditions, total protein preparations (a mix of proteins secreted into the culture medium and contained within intact bacteria) and cleared supernatant samples were fractionated by SDS-PAGE, immunoblotted, and detected by use of relevant rabbit polyclonal antisera. As expected, when grown under inducing conditions, the wild-type strain produced elevated levels of PopB and PopD (figure 2, left panel, lane b) that were readily secreted ( figure 2, right panel, lane b) . However, these levels were drastically decreased in the absence of PcrH, regardless of growth conditions ( figure 2, right panel, lanes c and d) . Wild-type levels of synthesized and secreted PopB and PopD could be restored in the cis-complemented strain PAKpcrH + , where a wild-type pcrH allele was reintroduced by allelic exchange into the DpcrH null mutant chromosome to restore expression of pcrH from its native promoter ( figure 2, lanes e and f) . To ensure that the loss of PopB and PopD was not due to reduced popB and popD expression, we analyzed transcription levels in both the wild-type and DpcrH null mutant. Using RT-PCR, we readily visualized amplified DNA specifically derived from reverse-transcribed popB and popD transcripts originating from P. aeruginosa, regardless of the presence or absence of PcrH ( figure 3) . As a control, we confirmed that no pcrH transcript was detected in the DpcrH null mutant, nor was DNA amplified from mRNA samples not subjected to reverse transcription (data not shown). These data are consistent with a role for PcrH in specifically stabilizing the PopB and PopD type III substrates.
PcrH ensures efficient effector translocation into eukaryotic cells. PopB and PopD are both essential for the translocation of exoenzyme cytotoxins into target cells [8] . This is readily visualized by a rapid rounding up of infected HeLa cell monolayers in response to exoenzyme cytotoxin delivery into the target cell cytosol [42] [43] [44] [45] [46] . Therefore, we assayed whether the DpcrH null mutant was deficient in translocation. In contrast to wild-type P. aeruginosa (figure 4A), the DpcrH null mutant was unable to induce a morphological change of infected HeLa cell monolayers because of its inability to translocate the cytotoxins ( figure 4B ). This finding correlates with the inability of this mutant to stably maintain and efficiently secrete the PopB and PopD translocator proteins, because this strain exhibits a cytotoxic response indicative of wild type when ciscomplemented with PcrH ( figure 4A and 4C) . Collectively, these data confirm that PcrH is required for the presecretory stability and efficient secretion of PopB and PopD, as a prerequisite for translocation. This function is presumably mediated via a protein-protein interaction.
PcrH interacts with PopB and PopD in the yeast 2-hybrid assay. To investigate the potential interaction between PcrH and PopB or PopD, we took advantage of the yeast 2-hybrid assay. The popB and popD genes of P. aeruginosa PAK were separately cloned into the GAL4 DNA-binding domain plasmid pGBKT7 to generate pJEB60 and pJEB58, respectively. Similarly, the pcrH gene was cloned into the GAL4 activation domain plasmid pGADT7, yielding pJEB56. We ensured that comparable levels of each protein fusion were detectable in yeast protein extracts by use of immunoblotting techniques with monoclonal antibodies to either the GAL4 DNA-binding domain or the GAL4 activation domain (figure 5). When each plasmid was individually introduced into the reporter yeast strain S. cerevisiae PJ69-4A, it did not result in ADE2 or lacZ reporter gene activation (table 2) . Significantly, when either pJEB60 (PopB + ) or pJEB58 (PopD + ) was transformed into PJ69-4A containing pJEB56 (PcrH + ), the ADE2 reporter gene was activated to allow growth of yeast on minimal media devoid of adenine. Levels of bgalactosidase activity produced from the second independent lacZ reporter gene confirmed these interactions. In addition, this reporter gene was activated irrespective of the growth temperature (25ЊC or 30ЊC), indicating an apparently strong interaction between PopB-PcrH and PopD-PcrH (table 2 and data not shown), as has been recently suggested [28] . Thus, we define PcrH of P. aeruginosa as a member of the translocator-class of type III secretion chaperones.
PcrH of P. aeruginosa can restore translocation by Y. pseudotuberculosis defective for LcrH.
Having established a chaperone role for PcrH and knowing that LcrH of pathogenic Yersinia species chaperones YopB and YopD [14] [15] [16] , we analyzed whether PcrH and LcrH are functionally interchangeable. Therefore, we cloned pcrH from P. aeruginosa PAK under the control of an IPTG-inducible promoter (pJEB46) and introduced this construct into a Yersinia DlcrH null mutant (YPIII/ pIB650) [26] . When grown in media with or without calcium, this mutant normally exhibits very low but detectable levels of either YopB or YopD ( figure 6 left panel, lanes c and d) [26] . However, either LcrH (pSEB1) or PcrH produced in trans could essentially restore wild-type levels of YopB and YopD synthesis in inducing conditions ( figure 6, left panel, lanes b, h, and l) . We interpret this to indicate that PcrH stabilizes presecretory YopB and YopD. However, we note that secretion of YopB was impaired in Yersinia species expressing PcrH, compared with that in Yersinia species expressing LcrH, whereas YopD was secreted normally ( figure 6, right panel, lanes b, h, and l) . In addition, even in the absence of IPTG induction, the leaky P tac promoter enabled sufficient LcrH product to be synthesized (although not easily detected by immunoblotting) for the stability ( figure 6 , left panel, lane f) and secretion (figure 6, right panel, lane f) of both YopB and YopD; however, the low levels of PcrH produced from the same leaky promoter (in the absence of IPTG) were only sufficient to restore stability and secretion of YopD ( figure 6, lane j) . Nevertheless, we wondered whether the portion of secreted YopB and YopD was sufficient to restore Yop effector translocation by the PcrH-producing strain. As is the case for P. aeruginosa exoenzymes, the translocation of the YopE cytotoxin, a GTPase-activating protein for the Rho family of GTP-binding proteins [47, 48] , can be effectively measured by a change in morphology of Yersinia species-infected HeLa cells during a tissue culture monolayer cytotoxicity assay [49] . HeLa cells were infected with either a wild-type strain (YPIII/pIB102) or a DlcrH null mutant harboring PcrH (YPIII/pIB650 and pJEB46). Both strains induced an indistinguishable morphological change of infected cells that was reminiscent of the action of the translocated YopE cytotoxin ( figure 7A and 7C) . No significant delay in cytotoxicity was observed for the complemented strain, compared with that of the wild-type strain, even though the levels of secreted YopB were impaired. We further confirmed the interchangeability of these chaperones by introducing pSEB1-Gm, harboring LcrH under the control of an inducible promoter, into the DpcrH null mutant of P. aeruginosa. LcrH was similarly able to restore the ability of this complemented strain to translocate effector molecules (exoenzymes) (data not shown). Collectively, these observations confirm that PcrH/LcrH exhibit similar functions to facilitate localization of effectors into infected cells.
Reciprocal binding of either the PcrH or LcrH chaperone to PopD/YopD but not to PopB/YopB. Although PcrH/LcrH are functionally similar, the observation that YopB secretion was impaired in the presence of noncognate PcrH is intriguing ( figure 6, right panel) . This introduces the likelihood of substrate preference among these type III chaperones. To further investigate this possibility, we wanted to examine whether the PcrH or LcrH chaperone could bind equally well to the substrates PopB/YopB or PopD/YopD. Again, we used the yeast 2-hybrid assay for this analysis, using the established P. aeruginosa clones described in the present study (popB, popD, and pcrH) and those of Y. pseudotuberculosis described elsewhere (yopB, yopD, and lcrH) [16] . We ensured that levels of each protein fusion were detectable in yeast protein extracts by immunoblotting (figure 5). When PcrH (pJEB56) and YopD (pMF367) or LcrH (pMF370) and PopD (pJEB58) were cotransformed into S. cerevisiae PJ69-4A, the ADE2 reporter gene was activated to allow growth of yeast on minimal media devoid of adenine (table 2) . Levels of b-galactosidase activity produced from the second independent lacZ reporter gene confirmed these interactions. In addition, the intensity of the PcrH-YopD and LcrHPopD interactions were comparable to native complex formation (i.e., PcrH-PopD and LcrH-YopD) (table 2) . Surprisingly, however, cotransformation of pMF368 (YopB) and pJEB56 (PcrH) or pJEB60 (PopB) and pMF370 (LcrH) into PJ69-4A did not result in reporter gene activation, even though native chaperonesubstrate complexes (PopB-PcrH and YopB-LcrH) were readily observed (table 2) . This striking finding was also recently reported elsewhere [28] . Thus, consistent with the observation that secretion of YopB was impaired in the presence of PcrH, these data clearly indicate that PcrH displays a nonreciprocal binding specificity toward native PopB of P. aeruginosa, in the same way that LcrH does toward YopB of Yersinia species.
PcrH is dispensable for regulation of type III secretion. It has recently become apparent that members of the translocator class of type III chaperones also impose a regulatory hierarchy on type III secretion [23] [24] [25] 50] . Indeed, the Yersinia species LcrH chaperone is no exception, because it co- Figure 5 . Expression of Yersinia pseudotuberculosis and Pseudomonas aeruginosa proteins in Saccharomyces cerevisiae PJ69-4A. Protein extracts were generated from yeast harboring either yopB (pYopB + ), yopD (pYopD + ), popB (pPopB + ), or popD (pPopD + ) fused to the GAL4 DNA-binding domain of pGBKT7 and either lcrH (pLcrH + ) or pcrH (pPcrH + ) fused to the GAL4 activation domain of pGADT7, respectively. Samples were separated by SDS-PAGE, and recombinant YopB, YopD, PopB, and PopD fusions were identified by immunoblotting with a GAL4 BD monoclonal antibody (MAb; Clontech Laboratories), whereas LcrH and PcrH fusions were detected with a GAL4 AD MAb (Clontech Laboratories). In each case, a protein extract from PJ69-4A alone (no plasmid) was included as a negative control. The asterisk indicates an unknown, low-molecular-weight, cross-reactive band. Molecular weights shown in parentheses are deduced from primary sequence. Biorad prestained low-range-protein molecular weight standards were used in this analysis. NOTE. ADE2 and lacZ are 2 independent reporter genes in Saccharomyces cerevisiae PJ69-4A. ADE2 + represents strong growth (++++) to no growth (Ϫ) on minimal medium devoid of adenine after 4 days incubation at 25؇C. b-Galactosidase activity is recorded in Miller units and is the mean of at least 5 independent measurements from liquid cultures of yeast cells grown at 25؇C. The SE of the mean was calculated by use of Axum software (version 5.0; Mathsoft).
operates with YopD to maintain stringent regulatory control [26, 27, 51] . In P. aeruginosa and Yersinia species, type III secretion is similarly induced by in vivo cell contact [52] [53] [54] or during in vitro growth in low levels of Ca 2+ [8, 9, 55] . Because this response in Yersinia species involves LcrH, we investigated whether P. aeruginosa defective for PcrH had lost regulatory control of type III secretion. Total protein preparations from wild-type or mutant bacteria grown under inducing (without Ca 2+ ) or noninducing (with Ca 2+ ) conditions were analyzed by immunoblotting. Levels of the exoenzyme effectors ExoT [56] and ExoS [57] and the pore-forming protein PcrV [5] were equally induced by both wild-type (PAK) and the DpcrH mutant (PAKpcrH) in medium without Ca 2+ , compared with media with Ca 2+ ( figure 2, left panel, lanes a-d) . In addition, we used RT-PCR to analyze the levels of exoT, exoS, and pcrV transcription in these same strains grown under identical conditions. Consistent with the lack of influence of PcrH on protein synthesis, the pattern of mRNA transcription from these alleles in wild-type and mutant bacteria were similar (figure 3)-that is, an increase in gene transcription, as measured by RT-PCR, was routinely observed when both bacterial strains were grown in media devoid of calcium.
The apparent lack of a regulatory phenotype observed in the DpcrH mutant is an important finding. Therefore, to verify this phenotype, we used an independent approach whereby we took advantage of the fact that PcrH could function in a Y. pseudotuberculosis mutant defective for LcrH. In the absence of LcrH, Y. pseudotuberculosis loses the ability to maintain regulatory control of Yop synthesis [26] . This result is borne out by the constitutive synthesis of Yops at 37ЊC, regardless of the presence or absence of calcium in the growth media. Concomitantly, this strain is also growth restricted after temperature increases from 26ЊC to 37ЊC, independent of calcium (termed "temperature sensitive" [TS]) [9, 26] , whereas wild-type Y. pseudotuberculosis requires calcium for growth at 37ЊC (termed "calcium dependent" [CD] ) and exhibits a normal pattern of Yop synthesis [9] . The regulatory defects associated with loss of LcrH are consistent with the requirement of a YopD-LcrH complex to maintain yop-regulatory control [26, 27] . In view of this, we investigated whether PcrH (pJEB46) could complement the TS phenotype displayed by the DlcrH (YPIII/pIB650) deletion mutant (table 3) . However, PcrH could not alter the TS growth phenotype of the DlcrH null mutant, even though native LcrH (pSEB1) could readily restore the growth defects from TS to CD (table 3) . The inability of the pcrH allele to complement the regulatory defects in Yersinia species was also reflected in constitutive Yop production at 37ЊC, regardless of Ca 2+ levels ( figure 6, left panel, lanes k and l) . In wild-type bacteria, however, distinct Yop production only occurred in media devoid of Ca
2+
. This is an intriguing finding, because PcrH can readily interact with YopD in the 2-hybrid assay (table 2) . Thus, these results collectively suggest that PcrH is not involved in regulatory control of type III secretion in P. aeruginosa, reinforcing that the LcrH-YopD complex is likely to be a regulatory component unique to the plasmid-encoded TTSS of Yersinia species [26] .
DISCUSSION
Several type III secretion substrates of P. aeruginosa are predicted to require a customized chaperone for their presecretory stabilization and efficient secretion. This phenomenon is evidenced by the presence of neighboring orf genes that are predicted to encode components with characteristics of type III secretion chaperones (such as small size and acidic pI) [5, 58] . However, only a few studies have confirmed their function [45, 59] . Even though Yahr et al. had earlier predicted that PcrH may chaperone the translocator proteins PopB and PopD [5] , and Allmond et al. recently showed that PcrH could bind both PopB and PopD [28] , the present study is the first to report that PcrH truly affects the stability and secretion of PopB and PopD but not of other type III-secreted proteins. In addition, because PcrH does not affect the transcription of popB and popD, it is unlikely that a mutation in pcrH directly affects PopB and PopD synthesis. Further evidence of a chaperone role for PcrH was gained from the demonstration of a direct and specific interaction between chaperone and substrates by use of the yeast 2-hybrid assay. Clearly, therefore, PcrH satisfies all requirements necessary to define it as the specific translocator-class chaperone for PopB and PopD.
The observation that some members of the translocator class of chaperones exhibit an additional regulatory function is fascinating. This offers a clear example of how bacteria establish a secretion hierarchy by ensuring that only proteins required at a particular time are produced [23] [24] [25] 50] . In Yersinia species, the translocator-class chaperone LcrH is intimately coupled to regulation of type III secretion [26, 27, 51] . However, we were unable to detect any regulatory defect in type III secretion by P. aeruginosa defective for PcrH, despite the fact that LcrH and PcrH share 59% identity [5] and that secretion of effector substrates by the type III mechanism is similarly induced in both Yersinia species and P. aeruginosa [23] . Although, at first glance, this result may seem surprising, the recently completed P. aeruginosa genome-sequencing project revealed that this bacterium possesses the capacity to encode for an unusually high proportion of regulatory factors [37] . Because a transposon mutagenesis study revealed that some of these factors are required for function of type III secretion [60] , they may overcome the need for a chaperone-dependent regulatory pathway in P. aeruginosa. In addition, Yersinia species use a negative regulatory element (LcrQ) to establish feedback inhibition of the TTSS [52, 61] . This pathway apparently requires a regulatory complex consisting of LcrH and YopD [26, 51, 62] . Because P. aeruginosa does not possess an LcrQ homologue [37] , the need for a regulatory complex involving PcrH appears to be bypassed. In our laboratory, efforts to understand the type III secretion regulatory phenomenon in P. aeruginosa are ongoing.
Using the yeast 2-hybrid assay, we observed that both PcrH and LcrH chaperones could bind strongly to the substrates PopD of P. aeruginosa and YopD of Y. pseudotuberculosis, which confirms findings in a recent report using affinity immunoblotting and glutathione S-transferase pull-down applications [28] . In addition, these data are consistent with each chaperone's equivalent ability to ensure efficient secretion of either the PopD or YopD substrate in Yersinia species [63] (present study). Because hydrophobic residues within the amphipathic domain of YopD are important for LcrH binding [16] , it is probable that chaperone binding to PopD is also mediated by these similar physical characteristics. On the other hand, it is intriguing that PcrH binding was specific for native PopB [28] (present study) and, likewise, that LcrH binding was specific for YopB (present study). We note that no specific LcrH binding domain was identified in YopB [15] , which suggests a distinctly different mode of LcrH binding to YopD, compared with that of binding to YopB. Unlike the cotranslocators YopD and PopD, the tertiary folding of YopB and PopB perhaps restricts their binding to just LcrH and PcrH, respectively. However, whether this explains the binding preferences remains to be investigated. Interestingly, a similar binding phenomenon was also observed for the type III chaperone-translocator systems of Salmonella species (SicA with SipB/C) and Shigella species (IpgC with IpaB/ C) [64, 65] . The implications of these chaperone-binding specificities are clearly functionally relevant and warrant further investigation.
In view of this binding phenomenon, we were initially surprised to find that defective effector translocation observed for the lcrH null mutant could be complemented by PcrH, even though secretion of YopB, a known translocator protein [12, 13, 66] , was reduced in this strain. However, that the requirement for only minor amounts of secreted translocator proteins to establish effector localization into eukaryotic cells appears to be a recurring theme is intriguing [63] . In addition, the reduced YopB secretion is also an interesting finding that might be explained by the presence of dual secretion signals. This occurrence is a well-established prerequisite for the efficient secretion of type III effector substrates, whereby a chaperoneindependent signal exists at the N-terminus and a second internal signal is mediated by cognate-chaperone binding [67, 68] . Thus, it is possible that YopB exhibits these dual secretion signals, but only in the presence of native LcrH, which can bind to YopB [15] (present study). In the presence of PcrH however, YopB secretion would solely depend on the N-terminal signal, because PcrH cannot bind to YopB (present study) to activate the chaperone-mediated secretion signal. The net effect of this is reduced YopB secretion in the presence of PcrH. Of importance, because dual-secretion signals play an essential role in establishing a secretion hierarchy [22] , these findings provide the basis for our further experimentation into the mechanism of type III secretion by bacterial pathogens.
The PopB and PopD translocator proteins are essential for functional type III secretion in P. aeruginosa [7, 8] . Therefore, it is of great importance to understand the mechanism by which trans-complemented with either pcrH or lcrH alleles under the control of an isopropyl-b-D-thiogalactopyranoside-inducible promoter. Determinations were made following at least 2 independent experiments, according to our standard protocols [9] . b CD, calcium dependent (bacteria grow only in the presence of Ca 2+ at 37؇C, reflecting wild-type regulatory control of Yop synthesis); TS, temperature sensitive (bacteria are growth restricted at 37؇C, reflecting defective regulatory control whereby Yop synthesis is constitutive).
the PcrH chaperone establishes efficient secretion of its substrates to ensure assembly of a functionally competent translocon apparatus. In particular, our ongoing investigations will focus on delineating the binding domains of both chaperone and substrates. Moreover, even though PcrH and LcrH share high identity at the amino acid level, notable substrate specificity is still observed [28] (present study). Thus, using these model chaperones, we seek to understand the molecular basis for the exquisite specificity normally displayed by this unique type III chaperone family.
TTSSs are viewed as potential antibacterial therapeutic targets [69] [70] [71] . It follows that the P. aeruginosa V-antigen, which is required for the translocation of the exoenzyme cytotoxins into infected cells, facilitates protective immunity to subsequent bacterial challenge in a variety of disease model systems [7, 72] . In addition, anti-PcrV antibodies can actively neutralize the TTSS of P. aeruginosa, at least for strain PA103, thereby preventing intracellular delivery of antihost exoenzymes [7, 73, 74] . However, because PcrV has only 1 TTSS homologue among known mammalian pathogens (i.e., LcrV of Yersinia species [5] ), this therapeutic approach is not suitable for treatment of a broad spectrum of bacterial infections. Therefore, we suggest that the critically conserved functions of the large family of translocator-class chaperones, which includes PcrH, make them ideal targets for future drug discoveries. In this case, 1 drug could presumably be used to neutralize a wide variety of bacterial pathogens that harbor a common TTSS. This proposal is made all the more attractive, because a precedent already exists for the use of chaperones as useful drug targets. Uropathogenic E. coli use pili for bacterial attachment to host tissue. Assembly of these cell-surface extensions requires chaperones, such as FimC and PapD [75, 76] . In the absence of these chaperones, pili are not formed, preventing bacterial colonization of host tissue. Therefore, this biological role has made FimC and PapD useful targets for the development of several potential novel antibacterial agents directed against uropathogenic E. coli [77] . This highlights the potential therapeutic benefits of targeting the function of PcrH homologues found in numerous bacterial pathogens.
